Dublin, Jan. 23, 2026 (GLOBE NEWSWIRE) -- The "Clinical Trial Analytics Services Market - Global Forecast 2026-2032" report has been added to ResearchAndMarkets.com's offering. The clinical trial ...
In this free webinar, learn how to validate R for clinical use while maintaining appropriate controls. The featured speakers will discuss how R and SAS can be used together without undermining ...
The clinical trials arena is becoming increasingly data-driven, with demand growing for sponsors to have real-time data access and ongoing updates throughout a study rather than just a final report.
Participation supports national effort to unlock cures for pediatric cancer using artificial intelligence. NASHVILLE, ...
Clinical Decision Support System Market OverviewThe global clinical decision support system market is projected to expand at an approximate CAGR of around 10% throughout the forecast timeline, ...
SAN FRANCISCO--(BUSINESS WIRE)--Barnes-Jewish Hospital (BJH), a recognized regional leader in advanced cardiovascular services, partnered with Biome Analytics to leverage sophisticated data analytics ...
The global market for clinical data analytics is expected to grow at a compound annual growth rate of 12.5 percent by 2023, according to a Market Research Future report. Clinical data analytics ...
When choosing infrastructure to support clinical analytics, many healthcare organizations use a monolithic and siloed approach, which can hinder implementation and limit opportunities to scale up and ...
PRINCETON, N.J., Nov. 13, 2024 /PRNewswire/ -- EDETEK, Inc., a leading global provider of specialized software and services for the biopharma, devices, and diagnostics industries, is proud to announce ...
Application developers and solution partners often need to process healthcare data outside of the electronic medical record (EMR) system. EMRs are primarily designed to directly support individual ...
The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...
The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果